<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00308724</url>
  </required_header>
  <id_info>
    <org_study_id>H15958</org_study_id>
    <secondary_id>R01MH053932</secondary_id>
    <nct_id>NCT00308724</nct_id>
    <nct_alias>NCT00081393</nct_alias>
  </id_info>
  <brief_title>Treating Late-Life Generalized Anxiety Disorder (GAD) in Primary Care</brief_title>
  <official_title>Treating Late-Life Generalized Anxiety Disorder (GAD) in Primary Care</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Baylor College of Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute of Mental Health (NIMH)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Institutes of Health (NIH)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>The University of Texas Health Science Center, Houston</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Kelsey Research Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Kelsey-Seybold Clinic</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>VA Medical Center, Houston</agency>
      <agency_class>U.S. Fed</agency_class>
    </collaborator>
  </sponsors>
  <source>Baylor College of Medicine</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether cognitive behavior therapy (CBT) is
      effective in the treatment of generalized anxiety disorder (GAD) in adults age 60 and older
      in a primary care setting.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Generalized Anxiety Disorder (GAD) is one of the most common anxiety disorders among older
      adults. Anxiety in older adults is associated with decreased physical activity, poorer
      self-perceptions of health, decreased life satisfaction, and increased loneliness. Because
      many older adults with anxiety seek assistance in a medical setting, treatment has been
      primarily pharmacological. There is, however, limited evidence of the effectiveness of
      psychotropic medications. Given the potential difficulties in prescribing psychotropic
      medications in later life (e.g., increased adverse effects, potential drug interactions),
      psychosocial treatments may be important alternative or adjuncts.

      The treatment phase of this study lasts 10 weeks, during which patients will be randomly
      assigned to either cognitive behavior therapy (CBT) or usual care. Follow-up will last 12
      months after treatment completion, during which time patients will complete telephone
      assessments.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2004</start_date>
  <completion_date type="Actual">April 2015</completion_date>
  <primary_completion_date type="Actual">January 2008</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Anxiety</measure>
    <time_frame>Baseline and 3, 6, 9, 12 and 15 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Functional and health status</measure>
    <time_frame>Baseline and 3, 6, 9, 12 and 15 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life</measure>
    <time_frame>Baseline and 3, 6, 9, 12 and 15 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Satisfaction with CBT and general health care</measure>
    <time_frame>Baseline and 3, 6, 9, 12 and 15 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Service utilization</measure>
    <time_frame>Baseline and 3, 6, 9, 12 and 15 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Depression</measure>
    <time_frame>Baseline and 3, 6, 9, 12 and 15 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sleep quality</measure>
    <time_frame>Baseline and 3, 6, 9, 12 and 15 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Use of alcohol and other substances</measure>
    <time_frame>Baseline and 3, 6, 9, 12 and 15 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">148</enrollment>
  <condition>Generalized Anxiety Disorder</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Cognitive Behavior Therapy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Usual Care</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Cognitive Behavior Therapy</intervention_name>
    <description>8 to 10 in person CBT sessions up to 60 minutes in duration within a 12 week time period</description>
    <arm_group_label>1</arm_group_label>
    <other_name>CBT</other_name>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Telephone check-in</intervention_name>
    <description>Biweekly telephone calls to monitor symptom severity, an enhanced Usual Care condition</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Clinical diagnosis of Generalized Anxiety Disorder

        Exclusion Criteria:

          -  Active suicidal intent

          -  Current psychosis

          -  Current bipolar disorder

          -  Substance abuse within past month

          -  Cognitive impairment
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Melinda A. Stanley, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Baylor College of Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Houston Center for Quality of Care and Utilization Studies</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Wetherell JL, Lenze EJ, Stanley MA. Evidence-based treatment of geriatric anxiety disorders. Psychiatr Clin North Am. 2005 Dec;28(4):871-96, ix. Review.</citation>
    <PMID>16325733</PMID>
  </reference>
  <reference>
    <citation>Stanley MA, Kunik ME. Anxiety in primary care: a frontier for mental health services research. Med Care. 2005 Dec;43(12):1161-3.</citation>
    <PMID>16299425</PMID>
  </reference>
  <reference>
    <citation>Stanley MA, Hopko DR, Diefenbach GJ, Bourland SL, Rodriguez H, Wagener P. Cognitive-behavior therapy for late-life generalized anxiety disorder in primary care: preliminary findings. Am J Geriatr Psychiatry. 2003 Jan-Feb;11(1):92-6.</citation>
    <PMID>12527544</PMID>
  </reference>
  <verification_date>January 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 28, 2006</study_first_submitted>
  <study_first_submitted_qc>March 28, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 30, 2006</study_first_posted>
  <last_update_submitted>July 21, 2015</last_update_submitted>
  <last_update_submitted_qc>July 21, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 23, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Baylor College of Medicine</investigator_affiliation>
    <investigator_full_name>Melinda Stanley</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Generalized Anxiety Disorder</keyword>
  <keyword>Geriatric</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Disease</mesh_term>
    <mesh_term>Anxiety Disorders</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

